本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Tempest Therapeutics Inc.

9.92
+0.07000.71%
盤後9.920.00000.00%19:59 EDT
成交量:2.57萬
成交額:25.51萬
市值:4,404.64萬
市盈率:-0.51
高:10.42
開:10.03
低:9.73
收:9.85
52周最高:20.67
52周最低:5.35
股本:444.02萬
流通股本:416.38萬
量比:0.30
換手率:0.62%
股息:- -
股息率:- -
每股收益(TTM):-19.4955
每股收益(LYR):-19.4955
淨資產收益率:-322.57%
總資產收益率:-81.34%
市淨率:4.50
市盈率(LYR):-0.51

資料載入中...

2024/10/10

重要事件披露

Form 8-K - Current report
2024/08/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/12

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/08

重要事件披露

Form 8-K - Current report
2024/06/20

重要事件披露

Form 8-K - Current report
2024/06/14

重要事件披露

Form 8-K - Current report
2024/05/13

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/03/19

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/19

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/19

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/18

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/11/18

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/11/18

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments